---
title: "Why did ENDRA Life Sciences stock drop 60% overnight?"
description: "ENDRA Life Sciences stock (NASDAQ: NDRA) fell nearly 65% during Tuesday's trading to $0.07. The company priced a public offering of 61,538,461 common shares (or pre-funded warrants in lieu of shares) "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/205612536.md"
published_at: "2024-06-04T17:41:30.000Z"
---

# Why did ENDRA Life Sciences stock drop 60% overnight?

> ENDRA Life Sciences stock (NASDAQ: NDRA) fell nearly 65% during Tuesday's trading to $0.07. The company priced a public offering of 61,538,461 common shares (or pre-funded warrants in lieu of shares) along with Series A and Series B warrants. This offering is being made on a "best efforts" basis, with no guaranteed amount to be raised. ENDRA plans to use the net proceeds from this offering for general corporate purposes, including funding ongoing operations and further developing its technology. The offering is expected to close tomorrow, June 5th. ENDRA Life Sciences stock has declined by 94.95% year-to-date. NDRA has a 52-week high of $2.79 and a 52-week low of $0.069

ENDRA Life Sciences stock (NASDAQ: NDRA) fell nearly 65% to $0.07 during Tuesday's trading session. The company priced a total of 61,538,461 million common shares (or pre-financing subscription rights in lieu of shares), along with A series and B series warrants. This issuance was done on a "best efforts" basis, therefore no guaranteed amount was raised.

ENDRA plans to utilize the net proceeds from this offering for general corporate purposes, including funding daily operations and further developing its technology. The offering is expected to conclude tomorrow, June 5th.

ENDRA Life Sciences stock has already dropped by 94.95% year-to-date. NDRA's 52-week high is $2.79, and the 52-week low is $0.069

### Related Stocks

- [NDRA.US - Endra Life Sciences](https://longbridge.com/en/quote/NDRA.US.md)
- [29273B500.US - ENDRA LIFE SCIENCES INC](https://longbridge.com/en/quote/29273B500.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Yijia Group Corp. Becomes VitaNova Life Sciences | Yijia Group Corp. has officially changed its name to VitaNova Life Sciences Corporation, as per a recent SEC filing. The | [Link](https://longbridge.com/en/news/273895310.md) |
| ENDRA Life Sciences Reports TAEUS Device Matches MRI Accuracy in Liver Disease Study | ENDRA Life Sciences Inc. announced that its TAEUS® Liver device closely matches MRI accuracy in detecting liver fat frac | [Link](https://longbridge.com/en/news/268613978.md) |
| ENDRA Life Sciences Reports Positive Feasibility Study Results for TAEUS Liver Fat Quantification Device | ENDRA Life Sciences announced positive preliminary results from a feasibility study of its TAEUS Liver device for quanti | [Link](https://longbridge.com/en/news/266749309.md) |
| ENDRA Life Sciences reports third quarter cash burn down 30% to $1.2 million | ENDRA Life Sciences reported a 30% reduction in cash burn for Q3 2025, totaling $1.2 million, down from $1.7 million in  | [Link](https://longbridge.com/en/news/266209410.md) |
| ENDRA Life Sciences Raises $4.9 Million in Private Placement and Launches Crypto Treasury Strategy | ENDRA Life Sciences Inc. has successfully closed a private investment in public equity (PIPE) financing, raising approxi | [Link](https://longbridge.com/en/news/262429335.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
